Neurointerventional devices market seen reaching $3.91 billion by 2030

The Business Research Company says the global neurointerventional devices market is on track to grow from $2.76 billion in 2025 to $3.91 billion by 2030, driven by stroke, aneurysm and aging-population demand. North America held the biggest regional share in 2025, while image-guided procedures and less invasive stroke treatments are among the fastest-shifting trends.

Why it matters: - Neurointerventional devices are used in minimally invasive brain, spine, head and neck vessel procedures. - The market outlook points to continued demand for tools that restore blood flow, remove clots and repair aneurysms without open surgery. - Rising neurological disease rates and an aging population are expanding the need for faster diagnosis and treatment.

What happened: - The Business Research Company said the neurointerventional devices market will grow from $2.76 billion in 2025 to $2.97 billion in 2026. - The market is projected to reach $3.91 billion by 2030, implying a 7.1% compound annual growth rate. - North America held the largest market share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company published the update on Aug. 19, 2026, from London. - Download a free sample of the report. - View the full market report.

The details: - Historical growth has been driven by higher rates of stroke and aneurysms. - Improvements in catheter and stent technology have supported adoption. - More neurology specialist training has widened clinical use. - Hospitals have expanded neurovascular departments. - Minimally invasive procedures are becoming more common. - Forecast growth is tied to an aging global population. - Increased funding and research in neurovascular health is expected to support demand. - Comprehensive stroke centers are expanding. - Demand is rising for quicker reperfusion techniques. - Healthcare spending is increasing in developing economies. - Emerging trends include image-guided neurointerventional procedures. - The market is also shifting toward less invasive stroke treatments. - Flow diversion technologies are seeing broader adoption. - Rapid clot retrieval devices are gaining use. - Neurointerventional procedures are growing in emerging regions.

Between the lines: - The market forecast reflects a broader shift toward procedures that reduce patient risk and recovery time. - The combination of newer devices, more trained specialists and more stroke infrastructure suggests adoption is moving from specialized centers into wider clinical use. - The report’s emphasis on emerging regions signals room for growth beyond North America, even though North America remains the current leader. - An April 2024 Alzheimer's Association report said 6.5 million Americans age 65 and older had Alzheimer's dementia in 2022, rising to 6.9 million in 2024, underscoring the scale of age-linked neurological disease.

What's next: - The company expects image-guided procedures, flow diversion and clot retrieval technologies to shape the next phase of market growth. - Expanded stroke-center capacity and higher healthcare spending in developing markets are likely to support adoption through 2030. - The 2026 report version adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, hotspot infographics and updated trend analysis.

The bottom line: - Neurointerventional devices remain a growth market tied to stroke care, aging populations and the move toward minimally invasive treatment.